CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

BofA Securities Adjusts Price Target on AbbVie to $282 From $276

Neutral
AI Analysis

Summary

BofA Securities raised its price target on AbbVie from $276 to $282 per share, representing a modest upward revision of the analyst's valuation.

Importance:2/10
Sentiment:
0.20
price_targetanalyst_update
Related Companies

Read the original article

Published by yahoo_finance on September 8, 2026 12:12 PM

Read Original